Pascal Geldsetzer How Can We Improve the Response to Chronic Conditions in India?

Dr. Pascal Geldsetzer is based in the Department of Global Health and Population in the T.H. Chan School of Public Health at Harvard University. He received his medical degree from the University of Edinburgh in 2011. His main research focus is on how healthcare systems can most effectively respond to chronic conditions in low and middle-income countries. Geldsetzer’s research has received significant and repeated support from the largest, oldest and most prestigious German scholarship foundation, the Studienstiftung des deutschen Volkes. (https://scholar.harvard.edu/geldsetzer)

Area of Research

Public Health, Healthcare Delivery Models for Chronic Diseases

since 2018

Postdoctoral Research Fellow

Harvard University

Department of Global Health and Population

2014-2015

Postdoctoral Research Fellow

Harvard University

Department of Global Health and Population

2013-2014

Young Professionals Program (YPP)

Deutsche Gesellschaft für internationale Zusammenarbeit (GIZ)

2015-2017

Doctor of Science (ScD)

Harvard University

2011-2012

Master of Public Health (MPH)

Harvard University

2006-2011

Doctor of Medicine (MD)

University of Edinburgh

Prizes

- Harvard Graduate Student Award (2017)

- Young Investigator Award at the Conference on Retroviruses and Opportunistic Infections (CROI), Boston, MA (2016)

Fellowships

- German National Merit Scholar (“Studienstiftung des deutschen Volkes”) (2015 - today)

- International Initiative for Impact Evaluation (3ie) (2015-2018)

- Clinton Health Access Initiative (2014-2017)

- USAID (2015-2017)

- Elton John AIDS Foundation and Comic Relief - UK (2012-2014)

India suffers from a high prevalence of diabetes and raised blood pressure. In this video, PASCAL GELDSETZER presents a detailed analysis of the prevalence of both conditions in India and asks how they might be better treated and controlled. Using population-based data collected by the Indian government, Geldsetzer shows that there is huge variation in the prevalence of these conditions between different Indian states and that these conditions do not, as is sometimes assumed, only affect the wealthier strata of Indian society. With evident relevance for health authorities in India, the work also provides food for thought for authorities considering health interventions in other low and middle-income countries worldwide.

LT Video Publication DOI: https://doi.org/10.21036/LTPUB10654

Diabetes and Hypertension in India: A Nationally Representative Study of 1.3 Million Adults

  • Pascal Geldsetzer, Jennifer Manne-Goehler, Michaela Theilmann, Justine I. Davies, Ashish Awasthi, Sebastian Vollmer, Lindsay M. Jaacks, Till Bärnighausen and Rifat Atun
  • JAMA Internal Medicine
  • Published in 2018
Get Full Access
Pascal Geldsetzer, Jennifer Manne-Goehler, Michaela Theilmann, Justine I. Davies, Ashish Awasthi, Sebastian Vollmer, Lindsay M. Jaacks, Till Bärnighausen and Rifat Atun. "Diabetes and Hypertension in India: A Nationally Representative Study of 1.3 Million Adults." JAMA Internal Medicine 178 (2018): 363–372. doi:10.1001/jamainternmed.2017.8094.

Geographic and Sociodemographic Variation of Cardiovascular Disease Risk in India: A Cross-sectional Study of 797,540 Adults

  • Pascal Geldsetzer, Jennifer Manne-Goehler, Michaela Theilmann, Justine I. Davies, Ashish Awasthi, Goodarz Danaei, Thomas A. Gaziano, Sebastian Vollmer, Lindsay M. Jaacks and Till Bärnighausen
  • PLoS Medicine
  • Published in 2018
Pascal Geldsetzer, Jennifer Manne-Goehler, Michaela Theilmann, Justine I. Davies, Ashish Awasthi, Goodarz Danaei, Thomas A. Gaziano, Sebastian Vollmer, Lindsay M. Jaacks and Till Bärnighausen. "Geographic and Sociodemographic Variation of Cardiovascular Disease Risk in India: A Cross-sectional Study of 797,540 Adults." PLoS Medicine 15 (2018): e1002581. doi:10.1371/journal.pmed.1002581.